Navigation Links
Angiotech and Symphony Medical Announce Licensing Agreement
Date:1/17/2008

cal and clinical development of our products; the ability to obtain and enforce timely patent and other intellectual property protection for our technology and products; decisions, and the timing of decisions, made by health regulatory agencies regarding approval of our technology and products; the ability to complete and maintain corporate alliances relating to the development and commercialization of our technology and products; market acceptance of our technology and products; the competitive environment and impact of technological change; and the continued availability of capital to finance our activities. Given these uncertainties, assumptions and risk factors, readers are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained in this report to reflect future results, events or developments.

-------------------------

(1) Description and statistics taken from Canadian Association of Cardiac

Rehabilitation website found at: http://www.cacr.ca; Paus Jenssen,

L. Erik, Atrial Fibrillation Following Coronary Artery Bypass Grafting.

Canadian Association of Cardiac Rehabilitation (CACR) newsletter:

http://www.cacr.ca/news/news_0209.htm

(2) Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE,

Henderson WG, et al. Atrial fibrillation after cardiac surgery: a major

morbid event? Ann Surg 1997;226:501-11.

(3) Aranski SF, ShawDP, Adams DH, Rizzo RJ, Couper GS, VanderVliet

M. Predictors of atrial fibrillation after coronary artery surgery.

Current trends and impact on hospital resources.

Circulation 1996;94:390-7.

CONTACT: Angiotech Contacts: Jodi Regts, Angiotech Pharmaceuticals, Inc., (6
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
2. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
3. Angiotech to participate in RBC 2007 Healthcare Conference
4. Angiotech to participate in Bank of America 2007 Credit Conference
5. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
8. Angiotech to participate in UBS Global Life Sciences Conference
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... today (August 22nd), in the scientific journal ... Programme establish the effect of serotonin on sensitivity ... and optical techniques., "Serotonin is a small molecule ... of brain functions, from the control of sleep ... behaviours, This neurotransmitter is also popularly thought to ...
(Date:8/22/2014)... August 22, 2014 Ophthalmic drug ... interesting and challenging endeavors as the anatomy, physiology ... properties to the foreign substances. Ocular drug delivery ... self medication and minimal use of needles; also ... drugs and provides specific targeting within the ocular ...
(Date:8/22/2014)... 22, 2014 Research and Markets ... Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction ... to their offering. The global molecular ... 2013, and is expected to grow at a CAGR ... biology enzymes, kits, & reagents find applications in a ...
(Date:8/22/2014)... The identification of protein-coding variants ... accelerated by exome sequencing. Built on Roche NimbleGen’s ... SeqCap EZ Developer system has been a proven ... additionally present how he achieved coverage statistics similar ... mouse exome kits. With over 236,000 SNPs and ...
Breaking Biology Technology:From happiness to pain: Understanding serotonin's function 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 2Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 3Efficient Identification of Protein-Coding Variants in a Model Organism Through Exome Sequencing, New Webinar Hosted by Xtalks 2
... Technologies Inc. (IVT), a Canadian vaccine development company, announced ... stage company that develops DNA vaccines. This research will ... DepoVax(TM) vaccine delivery system to advance a therapeutic HIV ... deliver FIT Biotech,s GTU(R) MultiHIV DNA vaccine and our ...
... May 26 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" ... ), a leading manufacturer and supplier,of branded ... announced an,agreement to acquire a 37.5% stake ... ("Jiangsu Yanshen") from existing shareholders for a ...
... UPPSALA, Sweden, May 25 Beactica AB, the ... has entered,into an agreement with Cubist Pharmaceuticals, Inc. ... agreement, Beactica will use its Sprint(TM) surface plasmon,resonance ... pathogenic bacteria of interest to Cubist. Financial terms ...
Cached Biology Technology:ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine 2Simcere Pharmaceutical Group Announces Agreement to Acquire 37.5% Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. 2Simcere Pharmaceutical Group Announces Agreement to Acquire 37.5% Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. 3
(Date:8/21/2014)... AWI geologist Juliane Mller the Fram Strait is a key ... of this passage between Greenland and Svalbard warm Atlantic water ... the west side cold Arctic water masses and sea ice ... Atlantic. A considerable portion of the Atlantic water cools here ... layers. The circulation of the water caused in this manner ...
(Date:8/21/2014)... RUSTON, La. A team of researchers ... innovative method for using affordable, consumer-grade 3D ... implants that can contain antibacterial and chemotherapeutic ... team comprised of doctoral students and research ... nanosystems engineering programs collaborated to create filament ...
(Date:8/20/2014)... In a study of 158 pregnant teenagers in Rochester, ... and intentional consumption of ice, cornstarch, vacuum dust, baby ... new Cornell study. , Moreover, such teens had significantly ... not eat nonfood substances. , Pregnant teens, regardless of ... can lead to iron deficiency and anemia. Low iron ...
Breaking Biology News(10 mins):Arctic sea ice influenced force of the Gulf Stream 2Arctic sea ice influenced force of the Gulf Stream 3Louisiana Tech University researchers use 3D printers to create custom medical implants 2Louisiana Tech University researchers use 3D printers to create custom medical implants 3Pica in pregnant teens linked to low iron 2
... EAST LANSING, Mich. Climate change is already having an ... unless action is taken it,s only going to get worse, ... year,s meeting of the American Association for the Advancement of ... relations and retailing, organized a session titled "How Climate Change ...
... A new study released today in the EarlyView ... in Alaska, highlighting a shift in biomes caused by ... the Woods Hole Research Center and three other institutions ... an extensive and unique tree-ring data set. Patterns observed ...
... in the symphony of good news that usually accompanies ... in regenerative medicine, thanks to their ability to regenerate ... to markedly improve the effectiveness of many medical treatments ... for treating burn victims, and the treatment of leukemia ...
Cached Biology News:New study illustrates shifting biomes in Alaska 2Reprogrammed stem cells hit a roadblock 2
Designed for use with any of the Agencourt kits in tube format....
... dihydrochloride) is a fluorescent counterstain ... in color. The bright blue ... red fluorochromes such as rhodamine, ... DAPI can be used for ...
... a cytochrome P450 (CYP450) metabolite postulated to ... and cerebral vasculature. In rat cerebral microvessels, ... autoregulatory vasoconstriction. 20-HETE is excreted mainly as ... 20-HETE (20-40 pg/ml in human urine) is ...
... APAgene kits are designed to rapidly ... using our patented APA Technology. APAgene provides ... competitive price. All necessary ingredients are provided ... can be used for gap filling, localized ...
Biology Products: